This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature will be posted on Medscape on a weekly basis. July 29, ...

July 6, 2007 (updated September 11, 2007) — The safety labeling for ceftriaxone sodium injection ( Rocephin; Roche Pharmaceuticals, Inc) has been updated to describe the potential risks associated ...

Amid growing concern about antimicrobial resistance, researchers have identified a potential alternative to current first-line antibiotic therapy for genital gonorrhea. Results from G-ToG, the first ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

The FDA has notified healthcare professionals of an update to a previous alert from September 2007 addressing the interaction of ceftriaxone with calcium-containing products. At the FDA’s request, ...

FLORENCE — Several urgent care facilities across Lauderdale and Colbert counties have announced through their social media pages that they have placed a hold on all Rocephin (ceftriaxone) injections ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

FLORENCE — Several health care providers in the Shoals continue to press pause on giving the antibiotic injection ceftriaxone, which is commonly known as Rocephin, after reports of “adverse effects” ...

Please provide your email address to receive an email when new articles are posted on . Fewer early ventilator-associated pneumonia cases occurred among patients with brain injury receiving ...